Rani Therapeutics Holdings Inc Class A

Research Rani Therapeutics Holdings Inc Class A (RANI) on Bullrun: market cap USD 85.94M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerRANI
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 85.94M
• Financial periodFY2025
• RevenueUSD 1.63M
• Revenue growth58.9%
• Net income-USD 29.67M
• Free cash flow-USD 18.80M

Valuation Snapshot

latest market cap is USD 85.94M.

About Rani Therapeutics Holdings Inc Class A

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies.

Frequently asked questions

What is Rani Therapeutics Holdings Inc Class A's market cap?

Rani Therapeutics Holdings Inc Class A's market capitalization is USD 85.94M.

What does Rani Therapeutics Holdings Inc Class A do?

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States.